Showing results (621-630 of 754) with videos related to

Sort By:
Pageof 76
BMJ Open|June 14, 2023
Developing a patient decision aid for Achilles tendon rupture management: a mixed-methods studyJan F L Gan, Marnee J McKay, Caitlin M P Jones, et al.
The Journal of Experimental Medicine|February 24, 2000
CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosisP J Blair, J L Riley, D M Harlan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 2, 2013
Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley ratSusanne N E Boehn, Sonja Spahn, Sabine Neudecker, et al.
World Neurosurgery|October 10, 2025
Clinical Outcomes After Spine Surgery for Patients with Potentially Unstable Metastatic Spinal Disease (Spine Instability Neoplastic Score 7-12): A Systematic ReviewAnthony N Baumann, Grayson M Talaski, Omkar S Anaspure, et al.
Molecular Genetics and Metabolism Reports|July 14, 2016
Creatine transporter deficiency: Novel mutations and functional studiesO Ardon, M Procter, R Mao, et al.
Genes, Chromosomes & Cancer|September 11, 2001
Genetic imbalances revealed by comparative genomic hybridization in Ewing tumorsT Ozaki, M Paulussen, C Poremba, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
HIV Medicine|September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort studyC Hoffmann, M Hentrich, D Gillor, et al.
Pageof 76